nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Raltitrexed—Methotrexate—ankylosing spondylitis	0.0193	0.547	CbGdCrCtD
Orlistat—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.017	0.248	CbGbCtD
Orlistat—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0129	0.188	CbGbCtD
Orlistat—CYP3A4—Betamethasone—ankylosing spondylitis	0.0111	0.161	CbGbCtD
Orlistat—CYP3A4—Prednisolone—ankylosing spondylitis	0.0109	0.159	CbGbCtD
Orlistat—CYP3A4—Prednisone—ankylosing spondylitis	0.0103	0.15	CbGbCtD
Orlistat—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00643	0.0938	CbGbCtD
Orlistat—Alopecia—Dexamethasone—ankylosing spondylitis	0.00171	0.00191	CcSEcCtD
Orlistat—Alopecia—Betamethasone—ankylosing spondylitis	0.00171	0.00191	CcSEcCtD
Orlistat—Discomfort—Prednisolone—ankylosing spondylitis	0.0017	0.00189	CcSEcCtD
Orlistat—Angioedema—Triamcinolone—ankylosing spondylitis	0.00169	0.00189	CcSEcCtD
Orlistat—Haemoglobin—Prednisone—ankylosing spondylitis	0.00169	0.00189	CcSEcCtD
Orlistat—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00169	0.00189	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00169	0.0477	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00169	0.0477	CbGdCrCtD
Orlistat—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00168	0.00188	CcSEcCtD
Orlistat—Haemorrhage—Prednisone—ankylosing spondylitis	0.00168	0.00188	CcSEcCtD
Orlistat—Malaise—Triamcinolone—ankylosing spondylitis	0.00167	0.00187	CcSEcCtD
Orlistat—Malaise—Methylprednisolone—ankylosing spondylitis	0.00167	0.00186	CcSEcCtD
Orlistat—Vertigo—Triamcinolone—ankylosing spondylitis	0.00167	0.00186	CcSEcCtD
Orlistat—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00166	0.00185	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00166	0.047	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00166	0.047	CbGdCrCtD
Orlistat—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00165	0.00184	CcSEcCtD
Orlistat—Oedema—Prednisolone—ankylosing spondylitis	0.00165	0.00184	CcSEcCtD
Orlistat—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00163	0.00182	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00162	0.0459	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00162	0.0459	CbGdCrCtD
Orlistat—Cough—Triamcinolone—ankylosing spondylitis	0.00162	0.00181	CcSEcCtD
Orlistat—Convulsion—Triamcinolone—ankylosing spondylitis	0.00161	0.00179	CcSEcCtD
Orlistat—Convulsion—Methylprednisolone—ankylosing spondylitis	0.0016	0.00179	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00159	0.00177	CcSEcCtD
Orlistat—Myalgia—Triamcinolone—ankylosing spondylitis	0.00158	0.00176	CcSEcCtD
Orlistat—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00157	0.00176	CcSEcCtD
Orlistat—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00157	0.00175	CcSEcCtD
Orlistat—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00157	0.00175	CcSEcCtD
Orlistat—Infestation—Methotrexate—ankylosing spondylitis	0.00157	0.00175	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00156	0.00175	CcSEcCtD
Orlistat—Depression—Methotrexate—ankylosing spondylitis	0.00156	0.00174	CcSEcCtD
Orlistat—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00156	0.00174	CcSEcCtD
Orlistat—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00156	0.00174	CcSEcCtD
Orlistat—Discomfort—Triamcinolone—ankylosing spondylitis	0.00156	0.00174	CcSEcCtD
Orlistat—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00156	0.00174	CcSEcCtD
Orlistat—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00154	0.00172	CcSEcCtD
Orlistat—Renal failure—Methotrexate—ankylosing spondylitis	0.00154	0.00172	CcSEcCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisone—ankylosing spondylitis	0.00154	0.0436	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisone—ankylosing spondylitis	0.00154	0.0436	CbGdCrCtD
Orlistat—Angioedema—Dexamethasone—ankylosing spondylitis	0.00154	0.00172	CcSEcCtD
Orlistat—Angioedema—Betamethasone—ankylosing spondylitis	0.00154	0.00172	CcSEcCtD
Orlistat—Immune system disorder—Prednisone—ankylosing spondylitis	0.00152	0.0017	CcSEcCtD
Orlistat—Malaise—Dexamethasone—ankylosing spondylitis	0.00152	0.00169	CcSEcCtD
Orlistat—Malaise—Betamethasone—ankylosing spondylitis	0.00152	0.00169	CcSEcCtD
Orlistat—Oedema—Triamcinolone—ankylosing spondylitis	0.00151	0.00169	CcSEcCtD
Orlistat—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00151	0.00169	CcSEcCtD
Orlistat—Vertigo—Betamethasone—ankylosing spondylitis	0.00151	0.00169	CcSEcCtD
Orlistat—Vertigo—Dexamethasone—ankylosing spondylitis	0.00151	0.00169	CcSEcCtD
Orlistat—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00151	0.00168	CcSEcCtD
Orlistat—Infection—Triamcinolone—ankylosing spondylitis	0.0015	0.00168	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—ankylosing spondylitis	0.0015	0.0425	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—ankylosing spondylitis	0.0015	0.0425	CbGdCrCtD
Orlistat—Infection—Methylprednisolone—ankylosing spondylitis	0.0015	0.00167	CcSEcCtD
Orlistat—Insomnia—Prednisolone—ankylosing spondylitis	0.00149	0.00166	CcSEcCtD
Orlistat—Alopecia—Prednisone—ankylosing spondylitis	0.00149	0.00166	CcSEcCtD
Orlistat—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00148	0.00165	CcSEcCtD
Orlistat—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00148	0.00165	CcSEcCtD
Orlistat—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00148	0.00165	CcSEcCtD
Orlistat—Mental disorder—Prednisone—ankylosing spondylitis	0.00147	0.00165	CcSEcCtD
Orlistat—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00147	0.00164	CcSEcCtD
Orlistat—Malnutrition—Prednisone—ankylosing spondylitis	0.00146	0.00163	CcSEcCtD
Orlistat—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00146	0.00163	CcSEcCtD
Orlistat—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00146	0.00163	CcSEcCtD
Orlistat—Convulsion—Betamethasone—ankylosing spondylitis	0.00146	0.00163	CcSEcCtD
Orlistat—Convulsion—Dexamethasone—ankylosing spondylitis	0.00146	0.00163	CcSEcCtD
Orlistat—Myalgia—Dexamethasone—ankylosing spondylitis	0.00143	0.0016	CcSEcCtD
Orlistat—Myalgia—Betamethasone—ankylosing spondylitis	0.00143	0.0016	CcSEcCtD
Orlistat—Anxiety—Dexamethasone—ankylosing spondylitis	0.00143	0.00159	CcSEcCtD
Orlistat—Anxiety—Betamethasone—ankylosing spondylitis	0.00143	0.00159	CcSEcCtD
Orlistat—Discomfort—Betamethasone—ankylosing spondylitis	0.00141	0.00158	CcSEcCtD
Orlistat—Discomfort—Dexamethasone—ankylosing spondylitis	0.00141	0.00158	CcSEcCtD
Orlistat—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00141	0.00158	CcSEcCtD
Orlistat—Pain—Prednisolone—ankylosing spondylitis	0.00141	0.00157	CcSEcCtD
Orlistat—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00141	0.00157	CcSEcCtD
Orlistat—Hepatitis—Methotrexate—ankylosing spondylitis	0.00141	0.00157	CcSEcCtD
Orlistat—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0014	0.00156	CcSEcCtD
Orlistat—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00139	0.00155	CcSEcCtD
Orlistat—Vision blurred—Prednisone—ankylosing spondylitis	0.00138	0.00154	CcSEcCtD
Orlistat—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00138	0.00154	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00138	0.00154	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00138	0.00153	CcSEcCtD
Orlistat—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00137	0.00153	CcSEcCtD
Orlistat—Oedema—Betamethasone—ankylosing spondylitis	0.00137	0.00153	CcSEcCtD
Orlistat—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00137	0.00153	CcSEcCtD
Orlistat—Oedema—Dexamethasone—ankylosing spondylitis	0.00137	0.00153	CcSEcCtD
Orlistat—Insomnia—Triamcinolone—ankylosing spondylitis	0.00137	0.00153	CcSEcCtD
Orlistat—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00137	0.00152	CcSEcCtD
Orlistat—Infection—Betamethasone—ankylosing spondylitis	0.00136	0.00152	CcSEcCtD
Orlistat—Infection—Dexamethasone—ankylosing spondylitis	0.00136	0.00152	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00136	0.00152	CcSEcCtD
Orlistat—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00136	0.00152	CcSEcCtD
Orlistat—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00136	0.00151	CcSEcCtD
Orlistat—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00136	0.00151	CcSEcCtD
Orlistat—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00135	0.0015	CcSEcCtD
Orlistat—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00135	0.0015	CcSEcCtD
Orlistat—Angioedema—Prednisone—ankylosing spondylitis	0.00134	0.00149	CcSEcCtD
Orlistat—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00133	0.00149	CcSEcCtD
Orlistat—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00133	0.00148	CcSEcCtD
Orlistat—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00133	0.00148	CcSEcCtD
Orlistat—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00133	0.00148	CcSEcCtD
Orlistat—Malaise—Prednisone—ankylosing spondylitis	0.00132	0.00147	CcSEcCtD
Orlistat—Vertigo—Prednisone—ankylosing spondylitis	0.00132	0.00147	CcSEcCtD
Orlistat—Urticaria—Prednisolone—ankylosing spondylitis	0.00131	0.00146	CcSEcCtD
Orlistat—Fatigue—Triamcinolone—ankylosing spondylitis	0.0013	0.00146	CcSEcCtD
Orlistat—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0013	0.00145	CcSEcCtD
Orlistat—Pain—Triamcinolone—ankylosing spondylitis	0.00129	0.00144	CcSEcCtD
Orlistat—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00127	0.00142	CcSEcCtD
Orlistat—Convulsion—Prednisone—ankylosing spondylitis	0.00127	0.00142	CcSEcCtD
Orlistat—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00127	0.00141	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00125	0.0014	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00125	0.0014	CcSEcCtD
Orlistat—Myalgia—Prednisone—ankylosing spondylitis	0.00125	0.00139	CcSEcCtD
Orlistat—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00125	0.00139	CcSEcCtD
Orlistat—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00124	0.00139	CcSEcCtD
Orlistat—Anxiety—Prednisone—ankylosing spondylitis	0.00124	0.00139	CcSEcCtD
Orlistat—Alopecia—Methotrexate—ankylosing spondylitis	0.00124	0.00139	CcSEcCtD
Orlistat—Insomnia—Dexamethasone—ankylosing spondylitis	0.00124	0.00139	CcSEcCtD
Orlistat—Insomnia—Betamethasone—ankylosing spondylitis	0.00124	0.00139	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00124	0.00138	CcSEcCtD
Orlistat—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00123	0.00138	CcSEcCtD
Orlistat—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00123	0.00138	CcSEcCtD
Orlistat—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00123	0.00138	CcSEcCtD
Orlistat—Discomfort—Prednisone—ankylosing spondylitis	0.00123	0.00137	CcSEcCtD
Orlistat—Mental disorder—Methotrexate—ankylosing spondylitis	0.00123	0.00137	CcSEcCtD
Orlistat—Malnutrition—Methotrexate—ankylosing spondylitis	0.00122	0.00137	CcSEcCtD
Orlistat—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00121	0.00135	CcSEcCtD
Orlistat—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00121	0.00135	CcSEcCtD
Orlistat—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00121	0.00135	CcSEcCtD
Orlistat—Urticaria—Triamcinolone—ankylosing spondylitis	0.0012	0.00134	CcSEcCtD
Orlistat—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0012	0.00134	CcSEcCtD
Orlistat—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0012	0.00134	CcSEcCtD
Orlistat—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0012	0.00133	CcSEcCtD
Orlistat—Oedema—Prednisone—ankylosing spondylitis	0.0012	0.00133	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0012	0.00133	CcSEcCtD
Orlistat—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00119	0.00133	CcSEcCtD
Orlistat—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00119	0.00133	CcSEcCtD
Orlistat—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00119	0.00133	CcSEcCtD
Orlistat—Infection—Prednisone—ankylosing spondylitis	0.00119	0.00133	CcSEcCtD
Orlistat—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00119	0.00132	CcSEcCtD
Orlistat—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00119	0.00132	CcSEcCtD
Orlistat—Back pain—Methotrexate—ankylosing spondylitis	0.00118	0.00132	CcSEcCtD
Orlistat—Fatigue—Betamethasone—ankylosing spondylitis	0.00118	0.00132	CcSEcCtD
Orlistat—Fatigue—Dexamethasone—ankylosing spondylitis	0.00118	0.00132	CcSEcCtD
Orlistat—Pain—Dexamethasone—ankylosing spondylitis	0.00117	0.00131	CcSEcCtD
Orlistat—Pain—Betamethasone—ankylosing spondylitis	0.00117	0.00131	CcSEcCtD
Orlistat—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00117	0.00131	CcSEcCtD
Orlistat—Skin disorder—Prednisone—ankylosing spondylitis	0.00116	0.0013	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00116	0.00129	CcSEcCtD
Orlistat—Vision blurred—Methotrexate—ankylosing spondylitis	0.00115	0.00129	CcSEcCtD
Orlistat—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00114	0.00127	CcSEcCtD
Orlistat—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00113	0.00126	CcSEcCtD
Orlistat—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00113	0.00126	CcSEcCtD
Orlistat—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00112	0.00125	CcSEcCtD
Orlistat—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00112	0.00125	CcSEcCtD
Orlistat—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00111	0.00124	CcSEcCtD
Orlistat—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00111	0.00124	CcSEcCtD
Orlistat—Malaise—Methotrexate—ankylosing spondylitis	0.0011	0.00123	CcSEcCtD
Orlistat—Vertigo—Methotrexate—ankylosing spondylitis	0.0011	0.00123	CcSEcCtD
Orlistat—Urticaria—Dexamethasone—ankylosing spondylitis	0.00109	0.00122	CcSEcCtD
Orlistat—Urticaria—Betamethasone—ankylosing spondylitis	0.00109	0.00122	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00109	0.00122	CcSEcCtD
Orlistat—Dizziness—Prednisolone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Asthenia—Triamcinolone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Orlistat—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00108	0.00121	CcSEcCtD
Orlistat—Insomnia—Prednisone—ankylosing spondylitis	0.00108	0.00121	CcSEcCtD
Orlistat—Paraesthesia—Prednisone—ankylosing spondylitis	0.00107	0.0012	CcSEcCtD
Orlistat—Pruritus—Triamcinolone—ankylosing spondylitis	0.00107	0.00119	CcSEcCtD
Orlistat—Cough—Methotrexate—ankylosing spondylitis	0.00107	0.00119	CcSEcCtD
Orlistat—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00107	0.00119	CcSEcCtD
Orlistat—Convulsion—Methotrexate—ankylosing spondylitis	0.00106	0.00118	CcSEcCtD
Orlistat—Dyspepsia—Prednisone—ankylosing spondylitis	0.00105	0.00117	CcSEcCtD
Orlistat—Chest pain—Methotrexate—ankylosing spondylitis	0.00104	0.00116	CcSEcCtD
Orlistat—Myalgia—Methotrexate—ankylosing spondylitis	0.00104	0.00116	CcSEcCtD
Orlistat—Decreased appetite—Prednisone—ankylosing spondylitis	0.00104	0.00116	CcSEcCtD
Orlistat—Rash—Prednisolone—ankylosing spondylitis	0.00104	0.00116	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—ankylosing spondylitis	0.00104	0.00116	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00103	0.00115	CcSEcCtD
Orlistat—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00103	0.00115	CcSEcCtD
Orlistat—Fatigue—Prednisone—ankylosing spondylitis	0.00103	0.00115	CcSEcCtD
Orlistat—Headache—Prednisolone—ankylosing spondylitis	0.00103	0.00115	CcSEcCtD
Orlistat—Discomfort—Methotrexate—ankylosing spondylitis	0.00103	0.00115	CcSEcCtD
Orlistat—Dizziness—Triamcinolone—ankylosing spondylitis	0.001	0.00112	CcSEcCtD
Orlistat—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000999	0.00111	CcSEcCtD
Orlistat—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000998	0.00111	CcSEcCtD
Orlistat—Infection—Methotrexate—ankylosing spondylitis	0.000993	0.00111	CcSEcCtD
Orlistat—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000985	0.0011	CcSEcCtD
Orlistat—Asthenia—Betamethasone—ankylosing spondylitis	0.000985	0.0011	CcSEcCtD
Orlistat—Asthenia—Dexamethasone—ankylosing spondylitis	0.000985	0.0011	CcSEcCtD
Orlistat—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00098	0.00109	CcSEcCtD
Orlistat—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000978	0.00109	CcSEcCtD
Orlistat—Nausea—Prednisolone—ankylosing spondylitis	0.000977	0.00109	CcSEcCtD
Orlistat—Pruritus—Betamethasone—ankylosing spondylitis	0.000971	0.00108	CcSEcCtD
Orlistat—Pruritus—Dexamethasone—ankylosing spondylitis	0.000971	0.00108	CcSEcCtD
Orlistat—Skin disorder—Methotrexate—ankylosing spondylitis	0.00097	0.00108	CcSEcCtD
Orlistat—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000966	0.00108	CcSEcCtD
Orlistat—Vomiting—Triamcinolone—ankylosing spondylitis	0.000962	0.00107	CcSEcCtD
Orlistat—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00096	0.00107	CcSEcCtD
Orlistat—Rash—Triamcinolone—ankylosing spondylitis	0.000954	0.00106	CcSEcCtD
Orlistat—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000953	0.00106	CcSEcCtD
Orlistat—Rash—Methylprednisolone—ankylosing spondylitis	0.000952	0.00106	CcSEcCtD
Orlistat—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000951	0.00106	CcSEcCtD
Orlistat—Urticaria—Prednisone—ankylosing spondylitis	0.00095	0.00106	CcSEcCtD
Orlistat—Headache—Triamcinolone—ankylosing spondylitis	0.000948	0.00106	CcSEcCtD
Orlistat—Headache—Methylprednisolone—ankylosing spondylitis	0.000946	0.00106	CcSEcCtD
Orlistat—Body temperature increased—Prednisone—ankylosing spondylitis	0.000945	0.00105	CcSEcCtD
Orlistat—Abdominal pain—Prednisone—ankylosing spondylitis	0.000945	0.00105	CcSEcCtD
Orlistat—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000939	0.00105	CcSEcCtD
Orlistat—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000939	0.00105	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00091	0.00102	CcSEcCtD
Orlistat—Dizziness—Betamethasone—ankylosing spondylitis	0.000908	0.00101	CcSEcCtD
Orlistat—Dizziness—Dexamethasone—ankylosing spondylitis	0.000908	0.00101	CcSEcCtD
Orlistat—Insomnia—Methotrexate—ankylosing spondylitis	0.000904	0.00101	CcSEcCtD
Orlistat—Nausea—Triamcinolone—ankylosing spondylitis	0.000899	0.001	CcSEcCtD
Orlistat—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000897	0.001	CcSEcCtD
Orlistat—Nausea—Methylprednisolone—ankylosing spondylitis	0.000897	0.001	CcSEcCtD
Orlistat—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000881	0.000983	CcSEcCtD
Orlistat—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000879	0.000981	CcSEcCtD
Orlistat—Vomiting—Betamethasone—ankylosing spondylitis	0.000873	0.000974	CcSEcCtD
Orlistat—Vomiting—Dexamethasone—ankylosing spondylitis	0.000873	0.000974	CcSEcCtD
Orlistat—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000868	0.000969	CcSEcCtD
Orlistat—Rash—Dexamethasone—ankylosing spondylitis	0.000866	0.000966	CcSEcCtD
Orlistat—Rash—Betamethasone—ankylosing spondylitis	0.000866	0.000966	CcSEcCtD
Orlistat—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000865	0.000965	CcSEcCtD
Orlistat—Dermatitis—Betamethasone—ankylosing spondylitis	0.000865	0.000965	CcSEcCtD
Orlistat—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000863	0.000963	CcSEcCtD
Orlistat—Fatigue—Methotrexate—ankylosing spondylitis	0.000861	0.000961	CcSEcCtD
Orlistat—Headache—Dexamethasone—ankylosing spondylitis	0.00086	0.00096	CcSEcCtD
Orlistat—Headache—Betamethasone—ankylosing spondylitis	0.00086	0.00096	CcSEcCtD
Orlistat—Asthenia—Prednisone—ankylosing spondylitis	0.000858	0.000957	CcSEcCtD
Orlistat—Pain—Methotrexate—ankylosing spondylitis	0.000854	0.000953	CcSEcCtD
Orlistat—Pruritus—Prednisone—ankylosing spondylitis	0.000846	0.000944	CcSEcCtD
Orlistat—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000823	0.000919	CcSEcCtD
Orlistat—Diarrhoea—Prednisone—ankylosing spondylitis	0.000818	0.000913	CcSEcCtD
Orlistat—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000817	0.000912	CcSEcCtD
Orlistat—Nausea—Dexamethasone—ankylosing spondylitis	0.000815	0.00091	CcSEcCtD
Orlistat—Nausea—Betamethasone—ankylosing spondylitis	0.000815	0.00091	CcSEcCtD
Orlistat—Urticaria—Methotrexate—ankylosing spondylitis	0.000794	0.000886	CcSEcCtD
Orlistat—Dizziness—Prednisone—ankylosing spondylitis	0.000791	0.000882	CcSEcCtD
Orlistat—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00079	0.000881	CcSEcCtD
Orlistat—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00079	0.000881	CcSEcCtD
Orlistat—Vomiting—Prednisone—ankylosing spondylitis	0.00076	0.000848	CcSEcCtD
Orlistat—Rash—Prednisone—ankylosing spondylitis	0.000754	0.000841	CcSEcCtD
Orlistat—Dermatitis—Prednisone—ankylosing spondylitis	0.000753	0.00084	CcSEcCtD
Orlistat—Headache—Prednisone—ankylosing spondylitis	0.000749	0.000836	CcSEcCtD
Orlistat—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000736	0.000821	CcSEcCtD
Orlistat—Asthenia—Methotrexate—ankylosing spondylitis	0.000717	0.0008	CcSEcCtD
Orlistat—Nausea—Prednisone—ankylosing spondylitis	0.00071	0.000792	CcSEcCtD
Orlistat—Pruritus—Methotrexate—ankylosing spondylitis	0.000707	0.000789	CcSEcCtD
Orlistat—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000684	0.000763	CcSEcCtD
Orlistat—Dizziness—Methotrexate—ankylosing spondylitis	0.000661	0.000737	CcSEcCtD
Orlistat—Vomiting—Methotrexate—ankylosing spondylitis	0.000635	0.000709	CcSEcCtD
Orlistat—Rash—Methotrexate—ankylosing spondylitis	0.00063	0.000703	CcSEcCtD
Orlistat—Dermatitis—Methotrexate—ankylosing spondylitis	0.000629	0.000702	CcSEcCtD
Orlistat—Headache—Methotrexate—ankylosing spondylitis	0.000626	0.000698	CcSEcCtD
Orlistat—Nausea—Methotrexate—ankylosing spondylitis	0.000593	0.000662	CcSEcCtD
